Guys I think there is a simple explanation. BP be
Post# of 148175
He did some RO testing in our mono trial. He has confirmed that he did not do this in the combo trial.
My suspicion is that when the FDA requested our mono data, we sent in RO data with it, and the change from Tropism to RO was something the FDA didnt like. So, we are in the process of updating to a uniform test across both data sets.